[Pseudoresistance to DDAVP in diabetes insipidus].
D000281:Administration, Intranasal; D000328:Adult; D001127:Arginine Vasopressin / Q000627:therapeutic use*; D003894:Deamino Arginine Vasopressin / Q000008:administration & dosage / Q000627:therapeutic use*; D003919:Diabetes Insipidus / Q000188:drug therapy*; D004351:Drug Resistance; D006801:Humans; D008297:Male
D001127:Arginine Vasopressin; D003894:Deamino Arginine Vasopressin
DDAVP pseudorezisztencia diabetes insipidusban.